Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares, (euro)0.09 nominal value per share
-
Shares outstanding
-
75.4M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
69M
-
Shares change
-
-5.75M
-
Total reported value, excl. options
-
$6.5B
-
Value change
-
-$237M
-
Put/Call ratio
-
0.45
-
Number of buys
-
167
-
Number of sells
-
-112
-
Price
-
$94.15
Significant Holders of Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) as of Q3 2025
330 filings reported holding MRUS - Merus N.V. - Common Shares, (euro)0.09 nominal value per share as of Q3 2025.
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69M shares
of 75.4M outstanding shares and own 91.58% of the company stock.
Largest 10 shareholders include Paradigm Biocapital Advisors LP (4.37M shares), Avoro Capital Advisors LLC (3.54M shares), Commodore Capital LP (3.53M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (3.05M shares), HBK INVESTMENTS L P (2.85M shares), FMR LLC (2.81M shares), BlackRock, Inc. (2.17M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.13M shares), RTW INVESTMENTS, LP (2.03M shares), and Woodline Partners LP (1.67M shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.